NRX Pharmaceuticals, Inc

1201 N Market St Ste 600
Wilmington, DE 19801

NRx Pharmaceuticals, Inc., based in Wilmington, DE, is a clinical biopharmaceutical company dedicated to addressing the critical unmet needs of patients suffering from severe bipolar depression and post-traumatic stress disorder (PTSD), particularly in the context of suicidality. The company is pioneering innovative treatments, including NRX-101, the first oral medication in FDA trials for suicidal bipolar depression, aiming to transform mental health care.

With a focus on non-hallucinogenic, non-addictive, and non-neurotoxic therapies, NRx Pharmaceuticals leverages novel approaches targeting the NMDA receptor to develop potential breakthroughs for those facing life-threatening mental health challenges. The organization emphasizes hope through its ongoing clinical trials and a commitment to improving the lives of individuals affected by these serious conditions.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesDelawareWilmingtonNRX Pharmaceuticals, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.